Rockefeller Capital Management L.P. Imv Inc. Transaction History

Rockefeller Capital Management L.P.

  • $34.7 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$1.07 - $1.5 $4,280 - $6,000
-4,000 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$2.87 - $5.95 $2,870 - $5,950
-1,000 Reduced 20.0%
4,000 $17,000
Q2 2020

Aug 12, 2020
BUY
$1.52 - $3.63 $7,600 - $18,150
5,000 New
5,000 $16,000

About IMV Inc.

IMV Quotes by TradingView
  • Ticker IMV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,452,200
  • Description
  • IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...
More about IMV
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email